| Identification | Back Directory | [Name]
Benzamide, 2-(6-azaspiro[2.5]oct-6-yl)-4-[[(2-hydroxyethyl)sulfonyl]amino]-N-[6-[(2R)-2-methyl-4-morpholinyl]-2-pyridinyl]- | [CAS]
2410796-89-1 | [Synonyms]
AM-5308
(R)-AM-5308
Benzamide, 2-(6-azaspiro[2.5]oct-6-yl)-4-[[(2-hydroxyethyl)sulfonyl]amino]-N-[6-[(2R)-2-methyl-4-morpholinyl]-2-pyridinyl]- | [Molecular Formula]
C26H35N5O5S | [MOL File]
2410796-89-1.mol | [Molecular Weight]
529.65 |
| Chemical Properties | Back Directory | [density ]
1.40±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [form ]
Solid | [pka]
5.49±0.10(Predicted) | [color ]
White to light yellow | [InChIKey]
IUDCFCQNVQWCCI-LJQANCHMSA-N | [SMILES]
C(NC1=NC(N2CCO[C@H](C)C2)=CC=C1)(=O)C1=CC=C(NS(CCO)(=O)=O)C=C1N1CCC2(CC2)CC1 |
| Hazard Information | Back Directory | [Uses]
AM-5308 is a potent kinesin KIF18A inhibitor (WO2021211549A1, C13)[1]. | [Biological Activity]
AM-5308 is a potent kinesin KIF18A inhibitor (WO2021211549A1, C13)[1]. | [storage]
Store at -20°C | [References]
[1]. Marc Noel PAYTON, et al. Kif18a inhibitors for treatment of neoplastic diseases. WO2021211549A1. |
|
|